… the population pharmacokinetic parameters of gentamicin in a large group of premature …
clinical and physiopathological covariates on the pharmacokinetic profile of the drug. Moreover, …

… The purpose of this study was to characterize the population PK parameters of gentamicin
in a large cohort of preterm and term neonates and to investigate the influence of clinical, …

… to achieve an average steady-state serum caffeine concentration of 12 lgáml)1 (mean
value observed in our population) in premature infants of various weights and postnatal ages. …

… In conclusion, the population pharmacokinetics of caffeine are reported after intravenous
administration of a wide range of doses of caffeine citrate to 119 premature infants with apnea. …

… This study developed a population PK model for theophylline in premature Korean infants. …
of the CYP1A2 genotype on the PK of theophylline in premature infants. Our results show that …

… candidiasis in premature infants. The objective of this study was to characterize the
population pharmacokinetics (PK) and dosing requirements of fluconazole in infants with birth …

… to assess if a population pharmacokinetic (PK) model developed with data from infants to
adults is predictive of neonatal clearance and to evaluate what age range of prior PK data is …

Background The aim of this study was to describe acetaminophen developmental pharmacokinetics
in premature neonates through infancy to suggest age-appropriate dosing regimens…

… and bioavailability of caffeine in extremely premature infants undergoing extubation has …
develop a population pharmacokinetic model for caffeine in extremely low birth weight infants. A …

… , a population pharmacokinetic model of plasma oxycodone was built to describe the maturation
of oxycodone pharmacokinetics in infants … pharmacokinetics of oxycodone in infants and …